plasmalogen
Animal productexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 2, 2017 (NCT03295188)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05041088 | Phase 1 | Oct 6, 2021 | Neurological Associates, Neurological Associates of West Los Angeles, Prodrome Sciences |
| NCT03295188 | N/A | Oct 2, 2017 | BOOCS Clinic Fukuoka, Japanese Plasmalogen Society |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BOOCS Clinic Fukuoka | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Japanese Plasmalogen Society | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Neurological Associates | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Neurological Associates of West Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Prodrome Sciences | For profit | 1 | 0 | 1 | 2021 |
5 organizations
Page 1 / 1